Purchase Order 75F40123P00097
Award Date 4/20/23
Potential Completion Date 9/29/28
Potential Value $91K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order contract to Emulate Inc., a for-profit small business, with a potential value of $218,100.00. The contract is for the delivery of two (2) each of the Human Emulation System ZOE Culture Module 2 and two (2) each of the Orb Hub Module. Emulate's organ-on-a-chip technology is designed to model human biology and supports federal initiatives in areas like personalized medicine,...
- The Department of Health and Human Services Food and Drug Administration awarded a $213,100 firm fixed price purchase order to Emulate Inc. of Boston, Massachusetts. The contract will provide a human emulation system including an ORB-HM1 hub module, two used ZOE-CM2 culture modules, and one new ZOE-CM2 culture module with a one year warranty. Additionally, a service agreement will cover maintenance of the three used items for one year. Per the sole source solicitation, Emulate will satisfy the...
- The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced...
- The Department of Health and Human Services Food and Drug Administration awarded a $354,235 purchase order to Emulate Inc., doing business as Emulate, located in Boston, Massachusetts. The firm fixed price contract is for a Liver Human Emulation System to support the FDA's regulatory review processes. Per the original solicitation, the agency sought to procure a Liver-Chip, Quad-Culture Kits, Zoe Culture Modules, an Orb Hub Module and associated equipment with a simple user interface and small...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Emulate Inc., doing business as Emulate, a for-profit organization. The $200,300.00 contract is for the provision of a human emulation system, which is a set-aside for small businesses. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
- Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip technology, was awarded a $145,260 firm fixed-price purchase order by the Food and Drug Administration on August 1, 2024. The contract calls for delivery of the CHIP-S1 Stretchable Chip (catalog number 10231-2) with an ultimate completion date of August 31, 2024. This award was designated as a Total Small Business set-aside, recognizing Emulate's status as a small business entity. The Food and Drug Administration, a...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Emulate Inc. for the trade-in of a Zoe Culture Module 2. The contract has a ceiling value of $180,800 and a completion date of September 16, 2024. Emulate Inc., a for-profit organization that develops organ-on-a-chip technology, has received prior contract and grant awards from various federal agencies,...
- The Department of Health and Human Services' Food and Drug Administration awarded a $104,500 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the procurement of five liver human emulation system 24 pack quad liver chip kits. The place of performance will be Emulate's facilities in Boston, Massachusetts. The period of performance is one year, from June 27, 2023 through June 26, 2024. This contract has a total small business set aside designation. The liver chip kits...
- The Department of Health and Human Services Food and Drug Administration awarded a $203,019.58 firm fixed price purchase order to Government Scientific Source Inc. to fulfill a total small business set-aside requirement. The award delivers two Emulate Zoe culture modules, one Orb hub module, and one Orb rack module as requested in the solicitation to continue the agency's microphysiological systems research at its facilities in Silver Spring, Maryland. Government Scientific Source Inc. will...